Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, chol
Implications for multiple sclerosis in the era of the Affordable Care Act: the shifting managed care landscape.
A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms.
Cell type- and brain region-resolved mouse brain proteome.
Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival.
Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS.
Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.
Clinical and economic impact of five-year adherence to disease-modifying therapies in a commercially insured multiple sclerosis population.
Heterogeneity of Multiple Sclerosis Lesions in Multislice Myelin Water Imaging.
Aquaporin-1 Antibody in Neuromyelitis Optica Patients.
Exercise as a therapy for improvement of walking ability in adults with multiple sclerosis: A meta-analysis.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.
The Plant-Derived Chalcone 2,2',5'-Trihydroxychalcone Provides Neuroprotection against Toll-Like Receptor 4 Triggered Inflammation in Microglia.
BCG vaccine for clinically isolated syndrome and MS: Infections and protective immunity.
Anti-Aquaporin-4 Antibody Positivity in Neuromyelitis Optica Is Associated with Lesion Activity.
Optic neuritis, the most common initial presenting manifestation of multiple sclerosis in northern Iran.
Appendix: clinical evaluation and treatment of transverse myelitis.
Neurologic Disorders in Immunocompetent Patients with Autochthonous Acute Hepatitis E.
Early magnetic resonance detection of natalizumab-related progressive multifocal leukoencephalopathy in a patient with multiple sclerosis.
Perspectives on neuroreparative therapies for treating multiple sclerosis.
Treatment Satisfaction With Disease Modifying Therapies In Multiple Sclerosis: A Systematic Review of Studies Using The Treatment Satisfaction Questionnaire For Medication (Tsqm).
Antigen microarrays identify CNS-produced autoantibodies in RRMS.
Active Suppression Induced by Repetitive Self-Epitopes Protects against EAE Development.
Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.
Pages
« first
‹ previous
…
618
619
620
621
622
623
624
625
626
…
next ›
last »